Abstract: Aminoglycoside antibiotics represent a classical group of antimicrobials first discovered in the 1940s. Due to their ototoxic and nephrotoxic side effects, they are typically only used against Gram negative bacteria which have become resistant to other therapeutics. One family of aminoglycosides includes such compounds as butirosin, ribostamycin, neomycin, and kanamycin, amongst others. The common theme in these antibiotics is that they are constructed around a chemically stable aminocyclitol unit referred to as 2-deoxystreptamine (2-DOS). Four enzymes are required for the in vivo production of 2-DOS. Here, we report the structure of RbmB from Streptomyces ribosidificus, which is a pyridoxal 5 0 -phosphate dependent enzyme that catalyzes two of the required steps in 2-DOS formation by functioning on distinct substrates. For this analysis, the structure of the external aldimine form of RbmB with 2-DOS was determined to 2.1 Å resolution. In addition, the structure of a similar enzyme, BtrR from Bacillus circulans, was also determined to 2.1 Å resolution in the same external aldimine form. These two structures represent the first detailed molecular descriptions of the active sites for those aminotransferases involved in 2-DOS production. Given the fact that the 2-DOS unit is widespread amongst aminoglycoside antibiotics, the data presented herein provide new molecular insight into the biosynthesis of these sugarbased drugs.
Introduction
According to Dr. Thomas R. Frieden, former director of the US Centers for Disease Control and Prevention, the alarming rise of antibiotic resistance could bring about the "next pandemic." Without question, antibiotic-resistant strains of bacteria are a significant threat to human existence. The main methods that bacteria utilize to confer resistance to antibiotics include modifying the drug, physically removing it from the cell, or altering the target site so that it is no longer recognized by the antimicrobial agent. 1 Many antibiotics, such as penicillin, cephalosporin, vancomycin, and erythromycin A, amongst others, are derived from natural products. Indeed, these compounds, isolated from plants, bacteria, fungi, and many marine organisms have dramatically changed the course of human history. The "mining" of unusual organisms such as those that grow at high temperatures, in sewers, or in jungles, for example, has led to a dazzling array of important therapeutic compounds
As with any use of antibiotics, however, bacterial resistant strains arise. It is thus imperative to stay "ahead of the game" by developing new therapeutics. Within recent years it has become apparent that microbial genome mining is playing a key role in the discovery of novel compounds with antibiotic and antitumor activities. [2] [3] [4] [5] In particular, bacteria belonging to the genus Streptomyces are a known prolific source of natural compounds. On average, a Streptomyces genome contains $30 secondary metabolite gene clusters. 5 The focus of this investigation is on the pyridoxal 5'-phosphate (PLP)-dependent aminotransferase, RbmB, involved in the biosynthesis of ribostamycin derived from Streptomyces ribosidificus. 6 As shown in Scheme 1, ribostamycin, a broad spectrum aminoglycoside antibiotic, consists of three groups: 2-deoxystreptamine (2-DOS), D-neosamine, and D-ribose. The 2-DOS core is a common aglycone observed in various antibiotics including kanamycin, neomycin, gentamicin, and butirosin, amongst others. 7 Formation of the 2-DOS core initiates with RbmA catalyzing the conversion of glucose-6-phosphate to 2-deoxy-scyllo-inosose (2-DOI) as indicated in Scheme 1. RbmB catalyzes the next step in the pathway leading to the formation of 2-deoxy-scyllo-inosamine (2-DOIA). The enzyme responsible for the conversion of 2-DOIA to 3-amino-2-deoxy-scyllo-inosose (amino-DOI) has not yet been identified in S. ribosidificus, but has been studied in other aminoglycoside-producing bacteria. 7, 8 Finally, RbmB catalyzes the second amination reaction in the pathway to yield the 2-DOS core. It thus functions on both 2-DOI and amino-DOI. As noted above, RbmB is a PLP-dependent enzyme. Typically, these enzymes bind the PLP cofactor via a Schiff base with a conserved lysine residue, which is referred to as the internal aldimine. A transimination reaction occurs when an amino-containing substrate displaces the conserved lysine thereby leading to the so-called external aldimine.
Here, we describe the three-dimensional structure of RbmB in its external aldimine form with 2-DOS. In addition, we report the structure of a similar enzyme, BtrR from Bacillus circulans, also in Scheme 1. The structure of ribostamycin and the biochemical steps leading to the formation of 2-DOS.
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complex with its external aldimine. The results reported herein provide new details into substrate binding amongst these "dual functional" aminotransferases.
Results and Discussion
The structure of RbmB in its external aldimine form was solved to 2.1 Å resolution and refined to an overall R-factor of 18.5%. Shown in Figure 1 (a) is a ribbon representation of the RbmB dimer. The total buried surface area is extensive at $5600 Å 2 . Each subunit consists of 12 a-helices and 16 b-strands, and the active sites are separated by $28 Å . The RbmB architecture places it into the well characterized fold type I or aspartate aminotransferase family. 9 The a-carbons for the two subunits in the Figure 2 . Structure of BtrR from B. circulans. Electron density corresponding to the bound external aldimine is shown in stereo in (a). It was calculated as described in the legend to Figure 1 and contoured at 4r. A superposition of the BtrR and RbmB active sites is presented in (b). The RbmB and BtrR models are colored in yellow and teal, respectively. The top labels correspond to those amino acids in RbmB whereas the bottom labels refer to those found in BtrR. In the first structural analysis of BtrR, it was predicted that Trp 92 would have to swing away from the PLP cofactor. 10 The hypothesis was, indeed, correct as shown in stereo in (c). The structure of BtrR with bound PLP is highlighted in teal whereas the structure of BtrR determined in this investigation is displayed in light blue.
dimer superimpose with a root-mean-square deviation of 0.2 Å for 386 target pairs. The electron densities corresponding to the external aldimines in both subunits were unambiguous. Shown in Figure 1(b) is the observed electron density found in subunit 2. As indicated in Figure  1 The manner in which both BtrR and RbmB can accommodate the external aldimine form with 2-DOS has now been defined. However, how these enzymes bind 2-DOIA (Scheme 1) in the external aldimine form is still unknown. Clearly, the structure analysis of either of these enzymes in an external aldimine form with 2DOIA would address this 17 essential question. This work is in progress as we attempt to produce a soluble form of RbmA (Scheme 1) that can ultimately be utilized to produce the required reagents for this aspect of the investigation. Regardless, the research presented herein reports the first three-dimensional models for aminotransferases in their external aldimine forms that are involved in 2-DOS biosynthesis. Given the number of 2-DOS-containing aminoglycoside antibiotics that have been discovered to date, the data provide new insight into 2-DOS biosynthesis on a molecular level.
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Materials and Methods
Cloning of the genes encoding RbmB and BtrR
Genomic DNA from S. ribosidificus (NRRL B-11466) served as the polymerase chain reaction (PCR) template for gene amplification of rbmB. For the analysis of the B. circulans BtrR, a synthetic gene was constructed on the basis of its amino acid sequence. The gene was prepared for Escherichia coli optimized codon usage by Integrated DNA Technologies. The genes encoding RbmB or BtrR were ligated into pET28t vectors that ultimately generated proteins with Nterminal His 6 -tags. 12 
Protein expression and purification
The pET28t-rbmB or pET28t-btrR plasmids were used to transform Rosetta2(DE3) E. coli cells (Novagen). The cultures were grown in lysogeny broth supplemented with kanamycin (50 mg/L) and chloramphenicol (50 mg/L) at 378C with shaking until an optical density of 0.8 was reached at 600 nm. The flasks were cooled in an ice bath, and the cells were induced with 1 mM isopropyl b-D-1-thiogalactopyranoside and allowed to express protein at 218C for 24 h.
The cells were harvested by centrifugation and disrupted by sonication on ice. The lysate was cleared by centrifugation, and the recombinant proteins were purified utilizing nickel nitrilotriacetic acid resin (Qiagen) according to the manufacturer's instructions. The purified proteins were dialyzed against 10 mM Tris-HCl (pH 8.0) and 200 mM NaCl and concentrated to 15 mg/mL based on an extinction coefficient of 1.14 (mg/mL) 21 cm 21 for RbmB and 25 mg/mL based on an extinction coefficient of 0.73 (mg/mL) 21 cm 21 for BtrR.
Crystallization
Crystallization conditions were surveyed by the hanging drop method of vapor diffusion using a laboratory-based sparse matrix screen. The enzymes were tested for crystallization properties in the presence of 1 mM PLP and 5 mM 2-DOS. X-ray diffraction quality crystals of RbmB were grown from precipitant solutions composed of 24%-26% poly(ethylene glycol) 3350, 100 mM MgCl 2 , and 100 mM 3-(N-morpholino)-propanesulfonic acid (MOPS) (pH 7.0). The crystals belonged to the tetragonal space group P4 1 2 1 2 with unit cell dimensions of a 5 b 5 101.1 Å , and c 5 160.0 Å . The asymmetric unit contained one dimer. The crystals were prepared for X-ray data collection by serially transferring them to a cryoprotectant solution composed of 30% poly(ethylene glycol) 3350, 200 mM NaCl, 100 mM MgCl 2 , 1 mM PLP, 5 mM 2-DOS, 10% ethylene glycol, and 100 mM MOPS (pH 7.0). X-ray diffraction quality crystals of BtrR were grown from precipitant solutions composed of 15-17% poly(ethylene glycol) 5000, 200 mM NaCl, and 100 mM MOPS (pH 7.0). The crystals belonged to the orthorhombic space group P2 1 2 1 2 1 with unit cell dimensions of a 5 69.4 Å , b 5 74.8 Å , and c 5 180.1 Å . The asymmetric unit contained one dimer. The crystals were prepared for X-ray data collection by serially transferring them to a cryoprotectant solution composed of 22% poly(ethylene glycol) 5000, 300 mM NaCl, 1 mM PLP, 5 mM 2-DOS, 16% ethylene glycol, and 100 mM MOPS (pH 7.0).
X-ray data collection and processing
All X-ray data sets were collected in house using a Bruker AXS Platinum 135 CCD detector controlled with the PROTEUM software suite (Bruker AXS Inc.) The X-ray source was Cu Ka radiation from a Rigaku RU200 X-ray generator equipped with Montel optics and operated at 50 kV and 90 mA. The data sets were processed with SAINT and scaled with SADABS (Bruker AXS Inc.). Relevant X-ray data collection statistics are listed in Table I .
The structure of RbmB was solved by molecular replacement with PHASER 13 using as the search probe the coordinates of a previously determined version of BtrR (PDB 2C7T). 10 Iterative cycles of model building with COOT 14, 15 and refinement with REFMAC 16 reduced the R work and R free to 18.2% and 23.3%, respectively, from 50 to 2.1 Å resolution. The BtrR structure was determined by molecular replacement with PHASER. Iterative cycles of model building with COOT and refinement with REFMAC reduced the R work and R free to 19.0% and 23.9%, respectively, from 50 to 2.1 Å resolution.
Model refinement statistics for both structures are listed in Table I. 
